| Treatments (S-ABA mg∙L−1) | Ant (mg 100 g−1) | TPC (mg 100 g−1) | Flava | Car (μg 100 g−1) |
| Control (0) | 0.16 ± 0.03* c | 61.14 ± 5.02* c | 0.84 ± 0.04* b | 73.42 ± 8.26* a |
| 400 (BR) | 0.22 ± 0.03 b | 72.41 ± 4.34 b | 0.89 ± 0.04 b | 62.83 ± 4.21 b |
| 400 (BR) + 200 (25 DAFA) | 0.30 ± 0.03 a | 82.53 ± 4.96 a | 0.98 ± 0.13 ab | 74.74 ± 2.65 a |
| 400 (BR) + 400 (25 DAFA) | 0.25 ± 0.02 b | 78.99 ± 2.81 ab | 1.16 ± 0.16 a | 77.76 ± 6.68 a |
| CV (%) | 11.38 | 5.65 | 12.06 | 8.36 |